admin

The backbone of medical advancement is biotechnology, an industry wrought with the incredible potential of novel drug RD, but vulnerable to the risk of stringent regulatory approval processes. Within this volatile market, however, is the cannabis-biotech sub-sector – a market flourishing with opportunity, innovation, and deep roots of medical possibilities. Fueled by an increasing volume […]

Roberto and Maria’s 13-year-old daughter has Dravet syndrome which causes many severe seizures daily. But with the help of a cannabis compound, she’s been nearly seizure free.  It’s bed time for 13-year-old Viridiana. And as her parents, Roberto and Maria, read to her, they know their daughter’s own story is different than a normal child’s. […]

Roberto and Maria’s 13-year-old daughter has Dravet syndrome which causes many severe seizures daily. But with the help of a cannabis compound, she’s been nearly seizure free.  It’s bed time for 13-year-old Viridiana. And as her parents, Roberto and Maria, read to her, they know their daughter’s own story is different than a normal child’s. […]

An Israel-based contract research organization (CRO) is conducting a Ph II clinical trial for Axim’s cannabidiol (CBD) and Gabapentin chewing gum product. Under the services agreement, the unnamed CRO will conduct the double blind, randomized, single-center Phase II trial for AXIM Biotechnologies, Inc. The goal is to demonstrate the efficacy of Axim’s Gabapentin/CBD chewing gum […]

Leaf relief: Marijuana contains hundreds of chemicals, one of which seems to alleviate seizures. underworld111 / iStock A component of marijuana called cannabidiol eased seizures in children with Dravet syndrome, a potentially fatal form of epilepsy, in a late-stage clinical trial1. Dravet syndrome stems from mutations in sodium channels, most often in a gene called […]

LONDON, July 24, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 7 August, 2017 its third quarter financial results for the period ending 30 June, 2017. GW will also host a […]

An Israel-based contract research organization (CRO) is conducting a Ph II clinical trial for Axim’s cannabidiol (CBD) and Gabapentin chewing gum product. Under the services agreement, the unnamed CRO will conduct the double blind, randomized, single-center Phase II trial for AXIM Biotechnologies, Inc. The goal is to demonstrate the efficacy of Axim’s Gabapentin/CBD chewing gum […]

Welcome to the Inaugural 2017 Cannabis Trend Report. Created in conjunction with Civilized and Salar Media Group, we take a look at how cannabis is disrupting industry, culture, legislation, science and everything in between.  Over the next few years we will continue to see great advances in the industry as more states approve legal cannabis use. North […]

Hong Kong has issued a patent to Intec Pharma for its investigational Accordion Pill Carbidopa/Levodopa (AP-CD/LD) drug delivery for Parkinson’s disease symptoms in advanced patients. The patent (HK1158545) is titled “Carbidopa/Levodopa Gastroretentive Drug Delivery” and is scheduled to remain active until April 2029. The patent belongs to Intec’s IN-7 patent family that already includes patents in the U.S., European Union, […]

LONDON, July 24, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 7 August, 2017 its third quarter financial results for the period ending 30 June, 2017. GW will also host a […]

Technological advances have led to dramatic decreases in the cost of genetic sequencing, ushering in a genomics revolution that aspires to transform medicine. However, developing solutions that can effectively, efficiently, and affordably translate these advances to a clinical setting remains challenging, which is why two genomics companies, Congenica and Edico Genome, have partnered to offer […]